Apellis Appoints Philip Ferrone, MD, as Chief Medical Retina Advisor

Apellis Pharmaceuticals announced that retina specialist Philip Ferrone, MD, will join the company as Chief Medical Retina Advisor, effective March 18. 

“Phil is globally renowned for his leadership in retina, including as a past president of the American Society of Retina Specialists (ASRS), so we are delighted to welcome him to the Apellis team,” Caroline Baumal, MD, Chief Medical Officer, Apellis, said in a company news release. “Phil has extensive expertise in retina research and patient care, which will be invaluable as we continue to bring Syfovre to patients with GA and advance our retina pipeline.”  

Dr. Ferrone will continue to serve as the director of clinical research at Vitreoretinal Consultants in New York. He is a past president of the ASRS and has been on its board of directors for 18 years. He is also a past president of The Foundation of the ASRS, which aims to raise patient awareness and education about retina health. 

Dr. Ferrone has served as principal investigator in over 60 clinical trials investigating new treatments for retinal diseases, authored over 75 peer-reviewed medical manuscripts, six book chapters, and has given over 160 scientific presentations at national and international ophthalmology medical meetings.